ftInvstr
BAFNAPH · Healthcare ₹295.85 -1.99% Mkt Cap ₹703 Cr
← Search another stock

BAFNAPH

Healthcare Drug Manufacturers - Specialty & Generic
★ Watchlist ⧉ Add to bucket
₹295.85
-1.99% today · 30d +3.97%
as of 2026-09-04
Price · Daily Candles
AI narrative is temporarily unavailable for BAFNAPH. The deterministic sections below render from live data.
₹ Latest Earnings · Q ending 2026-06-30
REVENUE
₹27 Cr
-23.22% YoY
NET PROFIT
₹0 Cr
-97.78% YoY
OPM
9.8%
-6.28pp YoY
EPS
₹0.03
PE 92.0
◇ Sector Position
PEERPEROCE %
BAFNAPH92.0—
SUNPHARMA37.5721.44
DIVISLAB89.1821.56
ZYDUSLIFE24.6424.22
+ 2 more peers — sign in to view
ML Forward Growth Predictions 🔒

9 ML-predicted forward-growth ranks across sales, EBIT, and FCF.

Sign up freeSign in
63
SCORE / 100
Overall
6-axis composite of the sections below.
Performance STRONG 100
Valuation STRETCHED 20
Growth MUTED 40
Profitability DECENT 55
Technicals STRONG 73
Risk LOW 90
Key Stats
TTM PE
92.0
P/B
7.44
52W HIGH
₹318.85
OFF HIGH
-7.21%
MKT CAP
₹703 Cr
◉ Active Signals
MACDBullish2.545
RSI(14)Bullish63.38
⧉ Strategy Fit 🔒

See which of ftInvstr's 50+ strategies hold BAFNAPH and at what entry.

Sign up freeSign in
AI-generated research based on publicly available data and ftInvstr's bias-safe quantitative models. Not investment advice. Past performance does not guarantee future results. Consult a SEBI-registered investment adviser before making any investment decision.